ArticleFrontiers in oncology2020

Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma.

Jingzhen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.